UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 122

Sortiert nach

Thrombosis and COVID-19 pneumonia: the clot thickens

The European respiratory journal, 2020-07, Vol.56 (1), p.2001608

2020

Link zum Volltext

Verfügbarkeit prüfen

British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations

Thorax, 2017-12, Vol.72 (12), p.1154

2017

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients

Science translational medicine, 2017-10, Vol.9 (413)

2017

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review

Critical care (London, England), 2010-01, Vol.14 (5), p.R169-R169

2010

Link zum Volltext

Verfügbarkeit prüfen

Outcome of cardiac surgery in patients with congenital heart disease in England between 1997 and 2015

PloS one, 2017-06, Vol.12 (6), p.e0178963-e0178963

2017

Link zum Volltext

Verfügbarkeit prüfen

The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension

Pharmacological research, 2011-06, Vol.63 (6), p.504-511

2011

Link zum Volltext

Verfügbarkeit prüfen

Echocardiographic Predictors of Outcome in Eisenmenger Syndrome

Circulation (New York, N.Y.), 2012-09, Vol.126 (12), p.1461-1468

2012

Link zum Volltext

Verfügbarkeit prüfen

miR-1-5p targets TGF-βR1 and is suppressed in the hypertrophying hearts of rats with pulmonary arterial hypertension

PloS one, 2020, Vol.15 (2), p.e0229409-e0229409

2020

Link zum Volltext

Verfügbarkeit prüfen

Survival in portopulmonary hypertension: Outcomes of the united kingdom national pulmonary arterial hypertension registry

The Journal of heart and lung transplantation, 2017-07, Vol.36 (7), p.770-779

2017

Link zum Volltext

Verfügbarkeit prüfen

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

Nature communications, 2024-01, Vol.15 (1), p.330-330, Article 330

2024

Link zum Volltext

Verfügbarkeit prüfen

Evidence for the Involvement of Type I Interferon in Pulmonary Arterial Hypertension

Circulation research, 2014-02, Vol.114 (4), p.677-688

2014

Link zum Volltext

Verfügbarkeit prüfen

EmPHasis-10 score for the assessment of quality of life in various types of pulmonary hypertension and its relation to outcome

European journal of preventive cardiology, 2019-08, Vol.26 (12), p.1338-1340

2019

Link zum Volltext

Verfügbarkeit prüfen

Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension

Biochemical and biophysical research communications, 2014-08, Vol.451 (1), p.8-14

2014

Link zum Volltext

Verfügbarkeit prüfen

Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients

Critical care (London, England), 2006-01, Vol.10 (2), p.R60-R60

2006

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary Arterial Hypertension: Iron Matters

Frontiers in physiology, 2018-05, Vol.9, p.641-641

2018

Link zum Volltext

Verfügbarkeit prüfen

miR‐424‐5p reduces ribosomal RNA and protein synthesis in muscle wasting

Journal of cachexia, sarcopenia and muscle, 2018-04, Vol.9 (2), p.400-416

2018

Link zum Volltext

Verfügbarkeit prüfen

BMP-9 induced endothelial cell tubule formation and inhibition of migration involves Smad1 driven endothelin-1 production

PloS one, 2012-01, Vol.7 (1), p.e30075

2012

Link zum Volltext

Verfügbarkeit prüfen

B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy

Heart (British Cardiac Society), 2012-05, Vol.98 (9), p.736-742

2012

Link zum Volltext

Verfügbarkeit prüfen

Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary Centre

Circulation (New York, N.Y.), 2015-12, Vol.132 (22), p.2118-2125

2015

Link zum Volltext

Verfügbarkeit prüfen

Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: Challenges and future directions

International journal of cardiology, 2015-05, Vol.187, p.401-403

2015

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension

Pulmonary circulation, 2024-01, Vol.14 (1), p.e12310-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells

Respiratory research, 2015-09, Vol.16 (1), p.114, Article 114

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

Nature communications, 2018-04, Vol.9 (1), p.1416-16, Article 1416

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(120)
Buchkapitel
(2)

Sprache

Englisch
(122)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Thrombosis and COVID-19 pneumonia: the clot thickens

British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations

Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients

Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review

Outcome of cardiac surgery in patients with congenital heart disease in England between 1997 and 2015

The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension

Echocardiographic Predictors of Outcome in Eisenmenger Syndrome

miR-1-5p targets TGF-βR1 and is suppressed in the hypertrophying hearts of rats with pulmonary arterial hypertension

Survival in portopulmonary hypertension: Outcomes of the united kingdom national pulmonary arterial hypertension registry

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

Evidence for the Involvement of Type I Interferon in Pulmonary Arterial Hypertension

EmPHasis-10 score for the assessment of quality of life in various types of pulmonary hypertension and its relation to outcome

Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension

Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)

Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients

Pulmonary Arterial Hypertension: Iron Matters

miR‐424‐5p reduces ribosomal RNA and protein synthesis in muscle wasting

BMP-9 induced endothelial cell tubule formation and inhibition of migration involves Smad1 driven endothelin-1 production

B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy

Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary Centre

Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: Challenges and future directions

Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension

Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells

Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

Suchergebnisse filtern